Milpharm
Generic pharmaceutical products for patients and healthcare providers in the UK, part of the Aurobindo group
Highlights
- New on EvolcAdded 2026-10-29
About Milpharm
Milpharm supplies a portfolio of over 170 generic pharmaceutical molecules in tablet, capsule and injectable forms across areas such as neurology, oncology, cardiovascular, anti-retrovirals, gastroenterology, anti-diabetics and anti-biotics.
Its customers are UK healthcare providers and patients, and the company operates as a supplier and distributor of generic medicines in the UK market.
Founded in 1997, Milpharm became part of the Aurobindo Pharma group in 2007 and is a wholly owned subsidiary of Aurobindo. Its registered seat is in Uxbridge, United Kingdom.
Product: Generic pharmaceutical products (tablets, capsules and injectables) across more than 170 molecules.
Jobs at Milpharm
More biotech & pharma companies
Mission Therapeutics
Develops small-molecule deubiquitylating enzyme (DUB) inhibitors for Parkinson's and other serious diseases, alone and with pharma partnersNew on EvolcMitorx Therapeutics
Develops mitochondrial-targeted small-molecule obesity treatments for people with metabolically unhealthy obesityNew on EvolcModelmole
AI-driven molecular discovery and drug development services for biotechnology and pharmaceutical companiesYoung companyNew on EvolcMoolec Science
Produces animal proteins and plant-based ingredients in crops such as soybean and safflower for food companies worldwideNew on EvolcMoredun Scientific
Contract research and biosafety testing for animal health, aquaculture and biopharmaceutical companiesNew on EvolcMyricx Pharma
Develops antibody-drug conjugate cancer therapies using payloads based on N-myristoyltransferase inhibitorsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Bootstrap
- Cloudflare
- Elementor
- WordPress
- jQuery